Navidea Biopharmaceuticals Incの資本の返還
Navidea Biopharmaceuticals Incの資本の返還は何ですか。
Navidea Biopharmaceuticals Incの資本の返還は80.10%です。
資本の返還の定義は何ですか。
株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
NYSEMKTのセクタHealth Careにおける資本の返還の企業と比べるNavidea Biopharmaceuticals Inc
Navidea Biopharmaceuticals Incは何をしますか。
navidea biopharmaceuticals, inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. it operates through two segments, diagnostic substances and therapeutic development programs. the company develops manocept platform to target the cd206 mannose receptor expressed on activated macrophages. its cd206-targeted drug platform is applicable to a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (pet), imaging and topical gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. further, the company offers nav4694, a fluorine-18 labeled pet imaging agent for use as an aid in the imaging and evaluation of patients with signs or symptoms of alzheimer's disease and mild cognitive impairment. in addition, it is de
Navidea Biopharmaceuticals Incと類似の資本の返還
- 4imprint plcの資本の返還は78.95%です。
- 3i Infotechの資本の返還は79.31%です。
- Jarvis Securities plcの資本の返還は79.44%です。
- The Cloroxの資本の返還は79.58%です。
- Opto Circuits (India)の資本の返還は79.62%です。
- Ortho Regenerative Technologiesの資本の返還は79.79%です。
- Navidea Biopharmaceuticals Incの資本の返還は80.10%です。
- Mineworx Technologiesの資本の返還は80.19%です。
- Pressure BioSciencesの資本の返還は80.33%です。
- Pitney Bowesの資本の返還は80.40%です。
- Automatic Data Processingの資本の返還は80.49%です。
- Newport Explorationの資本の返還は80.73%です。
- Stelrad Radiatorの資本の返還は80.74%です。